The abstract is read at the publisher; the summary is JClub's.
Patient-directed home testing and automated laboratory ordering with clinical decision support increased CKD testing in controlled studies, but rarely increased CKD diagnosis or GDMT prescribing.
- Why it matters: CKD is underdiagnosed and undertreated despite guideline-recommended annual eGFR and UACR testing and therapies that improve kidney and cardiovascular outcomes.
- What they did: A scoping review of 24 prospective controlled studies (26 reports) searched MEDLINE, Embase, and Web of Science through June 9, 2026, synthesizing testing and treatment implementation strategies.
- The result: Only 5 of 17 CKD treatment studies increased GDMT prescribing, with gains linked to longitudinal, team-based approaches such as pharmacist- or advanced practice provider-led management and proactive outreach.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.